Posted by Two Blokes
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy t
Source: Two Blokes Trading
Posted by Two Blokes
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy t
Source: Two Blokes Trading
Posted by Two Blokes
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy t
Source: Two Blokes Trading
Posted by Two Blokes
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy t
Source: Two Blokes Trading
Posted by Two Blokes
Strong AI tailwinds, defense end-market gains and Andrew's full-quarter impact keep APH's second quarter outlo
Source: Two Blokes Trading
Posted by Two Blokes
MOS opens $84M Brazil plant to boost fertilizer capacity and tap growth in the key MATOPIBA farming region.
Source: Two Blokes Trading
Posted by Two Blokes
Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Source: Two Blokes Trading
Posted by Two Blokes
Shelagh Glaser, CFO of Synopsys (SNPS), talks about the company's recent acquisition of Ansys. She believes it
Source: Two Blokes Trading
Posted by Two Blokes
TAP leans into premium brands like Peroni and Madri to lift margins. Yet, volume declines remain a hurdle.
Source: Two Blokes Trading
Posted by Two Blokes
Rocket Pharmaceuticals jumps 16.8% as FDA grants RMAT status to RP-A601 on positive phase I heart disease data
Source: Two Blokes Trading
Posted by Two Blokes
ET outpaces its industry with strong pipeline assets, strategic deals, and fee-based earnings driving steady g
Source: Two Blokes Trading
Posted by Two Blokes
DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics uni
Source: Two Blokes Trading